Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Docetaxel & Breast Cancer / Mammacarcinoma

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Docetaxel is a chemotherapy medication approved for the treatment of breast cancer by both the FDA in the United States and the EMA in the European Union.

The FDA has approved Docetaxel Injection for the treatment of breast cancer. It is specifically indicated for:

Use as a single agent in advanced breast cancer cases where other treatments have failed.

Combination therapy with doxorubicin and cyclophosphamide for operable node-positive breast cancer.

Docetaxel received FD…

Differential Benefit of Adjuvant Docetaxel-Based Chemotherapy in Patients With Early Breast Cancer According to Baseline Body Mass Index
Desmedt et al. 2020 JCO 38: 2883–2891
US Food and Drug Administration approval overview in metastatic breast cancer
Cortazar et al. 2012 J Clin Oncol 30(14): 1705-11
Review

7/1/2026